ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is 1.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $41,000 | -38.8% | 62,766 | +2.1% | 0.00% | – |
| Q4 2021 | $67,000 | -58.1% | 61,472 | -30.2% | 0.00% | – |
| Q3 2021 | $160,000 | -26.9% | 88,117 | +6.2% | 0.00% | – |
| Q2 2021 | $219,000 | -29.1% | 82,983 | -3.3% | 0.00% | – |
| Q1 2021 | $309,000 | +45.1% | 85,801 | +1.1% | 0.00% | – |
| Q4 2020 | $213,000 | +30.7% | 84,902 | +31.5% | 0.00% | – |
| Q3 2020 | $163,000 | -29.4% | 64,573 | -8.1% | 0.00% | – |
| Q2 2020 | $231,000 | +87.8% | 70,302 | +39.9% | 0.00% | – |
| Q1 2020 | $123,000 | -44.3% | 50,260 | +7.3% | 0.00% | – |
| Q4 2019 | $221,000 | +16.9% | 46,844 | +6.2% | 0.00% | – |
| Q3 2019 | $189,000 | -19.6% | 44,107 | +9.3% | 0.00% | – |
| Q2 2019 | $235,000 | +63.2% | 40,341 | +8.1% | 0.00% | – |
| Q1 2019 | $144,000 | +105.7% | 37,316 | -0.4% | 0.00% | – |
| Q4 2018 | $70,000 | -51.0% | 37,464 | -16.0% | 0.00% | – |
| Q3 2018 | $143,000 | +22.2% | 44,623 | +14.4% | 0.00% | – |
| Q2 2018 | $117,000 | -28.7% | 38,990 | -6.8% | 0.00% | – |
| Q1 2018 | $164,000 | -5.2% | 41,854 | -0.2% | 0.00% | – |
| Q4 2017 | $173,000 | +38.4% | 41,957 | +105.8% | 0.00% | – |
| Q3 2017 | $125,000 | -16.7% | 20,386 | -15.2% | 0.00% | – |
| Q2 2017 | $150,000 | +5.6% | 24,046 | +7.5% | 0.00% | – |
| Q1 2017 | $142,000 | +18.3% | 22,373 | 0.0% | 0.00% | – |
| Q4 2016 | $120,000 | -2.4% | 22,373 | +2.6% | 0.00% | – |
| Q3 2016 | $123,000 | +5.1% | 21,806 | +2.0% | 0.00% | – |
| Q2 2016 | $117,000 | -22.0% | 21,388 | +5.5% | 0.00% | – |
| Q1 2016 | $150,000 | -9.1% | 20,264 | +2.1% | 0.00% | – |
| Q4 2015 | $165,000 | -5.7% | 19,851 | +2.3% | 0.00% | – |
| Q3 2015 | $175,000 | -15.9% | 19,404 | +12.2% | 0.00% | – |
| Q2 2015 | $208,000 | +47.5% | 17,292 | +32.1% | 0.00% | – |
| Q1 2015 | $141,000 | +27.0% | 13,089 | -52.5% | 0.00% | – |
| Q2 2014 | $111,000 | – | 27,534 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
| MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
| MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
| MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
| Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
| CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
| Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
| Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
| Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |